Award Recognizes HemoSonics’ Innovative Contributions and Exceptional Support in Advancing Diagnostic Hemostasis Solutions Across Premier’s Member Network...
Landmark trial to evaluate world’s first autonomous, electronic artificial urinary sphincter for stress urinary incontinence in men...
Next-Generation Platform Enhances Endoscopic Ultrasound Imaging to Support More Accurate and Efficient Diagnoses...
The FDA approval of Thermo Fisher’s Oncomine Dx Express Test marks a key advancement in precision oncology, enabling fast, accurate detection of EGFR exon 20 insertion mutations and guiding NSCLC patients to targeted treatments like ZEGFROVY....
Pivotal U.S. Trial Evaluates Safety and Effectiveness of Onyx™ for Managing Bleeding in Peripheral Vasculature...
New Platform Offers Three Genomic Tests to Tailor Treatment Strategies for Glioblastoma Patients ...
Next-generation embolic technology enables rapid resorption and improved patient comfort in minimally invasive neurointervention...
New AI-Driven Platform Aims to Revolutionize Early Detection, Personalization, and Access in Global Mental Health Care...
The regulatory milestone enables the use of Medtronic’s trusted vessel sealing technology on its Hugo™ robotic-assisted surgery platform, enhancing precision and expanding clinical versatility across Europe. ...
FDA-cleared Magnetic-Assisted Robotic Surgery (MARS™) platform achieves major clinical milestone, signaling growing adoption and impact in abdominal procedures across U.S. centers. ...
